Filter events

  • A MOOC in vaccinology. Institut Pasteur

    Institutional | 30.07.2015

    A MOOC in vaccinology

    A new MOOC developed by the Institut Pasteur will be launched on September 17, 2015. Thirty-one internationally renowned medicine professors, scientists, and public health professionals from many countries, will give a large overview of vaccinology: history, definitions, basic immunology, epidemiology, preclinical and clinical development, recent vaccines, and future challenges. This MOOC is dedicated to scientific medical students and health professionals.

  • The molecular crossbow: a vital weapon in the bacterial arsenal. © Institut Pasteur

    Research | 23.07.2015

    The molecular crossbow: a vital weapon in the bacterial arsenal

    Scientists have made a major breakthrough in understanding the molecular structure and workings of an important part of the arsenal employed by bacteria to destroy cells or other bacteria. This study focuses on the assembly mechanism and gives a detailed description of the architecture of a key component in the bacterial type VI secretion system

  • Dr Asier Saez-Cirion, Unité HIV, inflammation et persistance, Institut Pasteur

    Research | 21.07.2015

    The first case of prolonged remission in an HIV-infected child – an interview with Asier Saez-Cirion

    At the 8th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention, Dr Asier Saez-Cirion (HIV, Inflammation and Persistence Unit, Institut Pasteur) presented the world’s first case of prolonged remission, in a child being monitored in the French ANRS pediatric cohort.

  • Population of macrophages infected with HIV. First case of prolonged remission (12 years) in an HIV-infected child. © Institut Pasteur / Asier Saez-Cirion

    Press release | 20.07.2015

    First case of prolonged remission (12 years) in an HIV-infected child

    A young woman now aged 18 and a half, who at birth was HIV-infected via mother-to-child transmission, is in virological remission, despite not having taken any antiretroviral therapy for the last 12 years. This first case in the world of long-term remission in a child, monitored in the French ANRS pediatric cohort, is presented by Dr Asier Sáez-Cirión at the IAS conference in Vancouver.

  • International News | 17.07.2015

    Sara Eyangoh appointed to the TDR Scientific & Technical Advisory Committee (STAC)

    Sara Eyangoh, scientific Director and Head of the mycobacteriology unit of the Centre Pasteur du Cameroun has been officially appointed as a member of the Scientific & Technical Advisory Committee of the Special Programme for Research and Training in Tropical Diseases (TDR)

  • A cluster of type 3 cells (shown in green) in a mouse colon. The role of the microbiota in preventing allergies. © Institut Pasteur

    Press release | 10.07.2015

    The role of the microbiota in preventing allergies

    The microbiota is involved in many mechanisms, including digestion, vitamin synthesis and host defense. It is well established that a loss of bacterial symbionts promotes the development of allergies. Scientists at the Institut Pasteur have succeeded in explaining this phenomenon, and demonstrate how the microbiota acts on the balance of the immune system: the presence of microbes specifically blocks the immune cells responsible for triggering allergies.

  • International News | 10.07.2015

    Towards a stronger partnership with Mexico

    On the occasion of the Franco-Mexican convention on Health, which took place this Friday, July 10th  at the French National Academy of Medicine, Dr. Mercedes Juan López, Minister of Health of Mexico and Christian Bréchot, President of the Institut Pasteur signed a memorandum of understanding to regulate and strengthen the Franco-Mexican scientific collaborations.

  • Eligo Bioscience receives EUR 2 Million from Seventure Partners to develop smart antibiotics. Institut Pasteur

    Institutional | 09.07.2015

    Eligo Bioscience receives EUR 2 Million from Seventure Partners to develop smart antibiotics

    Eligo Bioscience, located at the Institut Pasteur in Paris, announced it received an investment of €2m in a seed round financing from Seventure Partners, one of Europe’s leaders in financing innovation and visionary investor in the microbiome field since 2008.

  • Institut Pasteur

    Press release | 25.06.2015

    MERS-CoV in South Korea: the Institut Pasteur is supporting the response

    Since May 20, 2015, South Korea has been facing an outbreak of MERS-CoV that began with a traveler who returned from the Middle East. To date (as of June 24, 2015), there have been 179 cases and 27 deaths in Korea. As part of its global health mission, the Institut Pasteur is actively involved in monitoring the development of the outbreak, through its dedicated outbreak investigation taskforce.

  • Three Ebola virus variants identified in Guinea. Institut Pasteur

    Press release | 24.06.2015

    Three Ebola virus variants identified in Guinea

    Sequencing the genome of Ebola virus strains circulating in Guinea has allowed scientists at the Institut Pasteur in Dakar and in Paris, the CNRS and the University of Sydney to retrace the spread of the virus and monitor its evolution in the country where the outbreak started. This research reveals the co-circulation in Guinea, particularly in the urban regions of the capital and neighboring towns, of three distinct variants of the virus whose mutations are described in an article published in Nature.


Pasteur museum

Welcome to Pasteur Museum


The Pasteur Museum is located at the Institut Pasteur, situated at: 25 rue du Docteur Roux 75015 Paris, France

Pasteur Museum